World’s first patient receives new-look heart pump | A Class I recall for J&J MedTech | ASE recommendations

The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 

Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.

The FDA previously shared an early alert about this issue, but it was still reviewing the situation at the time. The new recall covers a total of more than 11,000 devices.

Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

The patient, 61, had been bedridden for months due to end-stage heart failure and was not eligible for a heart transplant.

Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one. 

According to Medtronic, its VitalFlow ECMO system was designed and developed with the user experience in mind.